Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 2004 Oct;48(10):4059–4062. doi: 10.1128/AAC.48.10.4059-4062.2004

Rapid Detection and Sequence-Specific Differentiation of Extended-Spectrum β-Lactamase GES-2 from Pseudomonas aeruginosa by Use of a Real-Time PCR Assay

Gerhard F Weldhagen 1,*
PMCID: PMC521898  PMID: 15388481

Abstract

The LightCycler was compared to nested PCR for the detection of blaGES/IBC genes from 100 Pseudomonas aeruginosa clinical isolates. The real-time PCR assay detected a blaGES/IBC gene product from 83 isolates, exhibiting a sensitivity and specificity of 94.3 and 100% respectively, compared to nested PCR and DNA sequencing.


Detection of GES-2 and other extended-spectrum β-lactamase (ESBL)-producing Pseudomonas aeruginosa isolates in the clinical microbiology laboratory utilizing ordinary methods is notoriously difficult and laborious (20). Apart from the known distribution of GES/IBC-type ESBLs in P. aeruginosa and members of the family Enterobacteriaceae (18, 20), recent reports from Brazil and Japan show that these enzymes are present in P. aeruginosa and Klebsiella pneumoniae, respectively (3, 17). In addition, the integron genetic structures that support these ESBLs, such as GES-2, not only confer resistance to broad-spectrum β-lactam antibiotics but also to unrelated classes of antimicrobials (20), making these isolates very difficult to treat and control successfully. Apart from standard PCR and gene sequencing, molecular detection methods for ESBLs in general led to a wide array of applications most suited for the TEM- and SHV-type of ESBL families (1, 2, 6, 8, 10, 12, 16). This study describes the application of the LightCycler to rapidly and specifically detect blaGES-2 in the GES/IBC ESBL family from South African P. aeruginosa isolates.

Bacterial isolates and DNA extraction.

One hundred P. aeruginosa clinical isolates, identified and collected from 1998 to 2001, as described previously (19), were included in this study. Control isolates are listed in Table 1. Disk susceptibility testing was conducted as described previously (11, 19), with ceftazidime resistance being a requirement for inclusion. Extraction of whole-cell DNA was accomplished with an ethanol precipitation-based method (5, 13), with DNA extraction being visually verified (19).

TABLE 1.

Well-characterized bacterial strains used for standardization of molecular methods

Strain Relevant property Source or reference
P. aeruginosa GW-1 blaGES-2-producing isolate 14
P. aeruginosa Pu21 blaGES-2 transconjugant isolate 14
K. pneumoniae ORI-1 blaGES-1-producing isolate 15
Enterobacter cloacae HT-9 blaIBC-1-producing isolate 4
E. coli brcpHT-8 blaIBC-1 transconjugate isolate 4
E. coli DH5α blaIBC-2 transconjugant isolate 9
E. coli ATCC 25922 blaGES/blaIBC-negative strain ATCCa
a

ATCC, American Type Culture Collection, Manassas, Va.

LightCycler primer/probe design.

A fluorescence resonance energy transfer-mediated mutation assay was performed with the LightCycler as described previously (16), with reaction-specific modifications as necessary. Forward primer GES-C and previously described reverse primer GES-1B (Table 2) amplified a 689-bp product. A 3′ fluorescein isothiocyanate-labeled sensor probe was designed from the gene sequence of blaGES-1 (15), spanning the mutation site of nucleotides (nt) 493 and 494 of blaGES-2 (14) (Table 2). A 33-mer anchor probe (Table 2) was designed to bind at a distance of 1 nt directly downstream of the sensor probe. Design and placement of fluorogenic probes are depicted in Fig. 1.

TABLE 2.

Oligonucleotide sequences used in this study

Primer or probea Sequenceb Tm (°C) Position (nt) on blaGES Function Source or reference
Nested PCR
    GES-1A ATG CGC TTC ATT CAC GCA C 56.6 01-19 Forward primer 14, 20
    GES-1B CTA TTT GTC CGT GCT CAG G 56.4 846-864 Reverse primer 14, 20
    GES-C GTT TTG CAA TGT GCT CAA CG 54.6 176-195 Forward primer 19
    GES-D TGC CAT AGC AAT AGG CGT AG 55.6 527-546 Reverse primer 19
Real-time PCR
    GES-C As above
    GES-1B As above
    Probe 1 AGA TGG GCG ACA ACA CAC CT-FL 59.8 488-507 Sensor probe complementary to blaGES-1/blaIBC This study
    Probe 2 LC Red 640-GCG ACC TCA GAG ATA CAA CTA CGC CTA TTG CTA-PH 68.4 509-541 Anchor probe This study
a

Primers (GES designations) were synthesized and purified by integrated DNA Technologies, Coralville, Iowa.

b

Sequences are delineated 5′ to 3′ Fluorophore-labeled probes were synthesized and purified by TIB Molecular Biology, Berlin, Germany. Boldface letters depict the relevant point mutation. FL, fluorescein; PH, phosphorylation; LC Red 640, LightCycler Red 640.

FIG. 1.

FIG. 1.

Alignment of real-time PCR primer and fluorogenic probe sequences with blaGES-2. Stem-loop sequences appear in boxes, and arrows indicate the directions of stem-loop formation. The relevant nucleotide mismatch (nt 493 and 494) is depicted as a shaded box. Note the close approximation of the sensor probe to the stem-loop structure in addition to the 1-nt distance between the sensor and anchor probes. Also shown are forward and reverse primers (nt 488 to 507, sensor probe 3′ marked with fluorescein [FL]; and nt 509 to 541, anchor probe 5′ marked with LightCycler Red 640 [LCR640]).

LightCycler PCR.

The reaction mixture comprised a 0.5 μM concentration of each primer, a 0.2 μM concentration each of the sensor and anchor probes, 4 μl of LightCycler FastStart DNA MasterPLUS reaction mix (Roche Diagnostics, Penzberg, Germany), 5 μl of DNA template, and distilled water to a final reaction volume of 20 μl. DNA templates from control isolates (Table 1) and distilled water served as positive and negative controls, respectively. Amplification and melting curve analysis used in this study deviated from previously published data (16), as shown in Table 3. Data analysis was performed as previously described (16). Amplicons from control isolates (Table 1) were analyzed by agarose gel electrophoresis (16).

TABLE 3.

LightCycler amplification and melting curve protocol followed in this study

Program No. of cycles Target temp (°C) Hold time (s) Temp transition rate (°C/s) Fluorescence acquisition modea
Polymerase activation 1 95 600 20 None
Three-step PCR 40
    Denaturation cycle 96 1 20 None
    Amplification cycle 52 10 20 Single
    Extension cycle 72 15 20 None
Three-step melting curve 1
    Denaturation cycle 95 10 20 None
    Holding cycle 45 30 20 None
    Melting cycle 95 0 0.2 Continuous
a

Fluorimeter gains settings were F1 equal to 1, F2 equal to 15, and F3 equal to 30.

Nested PCR and DNA sequencing.

Primers GES-1A and GES-1B (Table 2) were used to amplify the entire blaGES/IBC coding region. Second-round amplification utilized primers GES-C and GES-D (Table 2) and 2 μl of the amplification product from the initial PCR, targeting a 371-bp region. Reaction conditions and controls were similar to those of a previously published standard PCR method (19). Automated sequencing of 371-bp amplicons was performed as previously described (19).

Results and discussion.

Results obtained with real-time PCR, nested PCR, and DNA sequencing methods are shown in Table 4. Electrophoresis of amplicons obtained from control isolates (Table 1) showed that all exhibited a 689-bp blaGES/IBC gene product except the Escherichia coli ATCC 25922 isolate (data not shown). No DNA template amplification was observed with distilled water controls. A stem-loop in the secondary DNA structure was noted as previously described (19). The LightCycler, based on real-time fluorimetric measurement of amplification products, proved ideal to analyze the “hot spot” area in the blaGES gene for resistance mutations, as previously described for Candida albicans isolates (7). Previous real-time PCR work conducted for the detection of SHV-type ESBLs from Enterobacteriaceae clinical isolates (16) found a 100% sensitivity and specificity for the described LightCycler assay. During this study, the LightCycler and nested PCR assays detected a blaGES/IBC product from 83 and 88 clinical isolates, respectively, exhibiting a sensitivity of 94.3% for the LightCycler compared to nested PCR and a 100% specificity compared to sequencing data. The noted decrease in sensitivity may have been influenced by a number of factors including the quality of the DNA template used in the experiments (20) and the choice of both DNA polymerase and polymerase buffer systems utilized in the LightCycler assay (21). Based on a previous study which demonstrated a ca. 6°C temperature shift per nucleotide mismatch (16) and due to the 2-nt mismatch between blaGES-2 and the sensor probe, a ca. 10 to12°C difference in melting temperature (Tm) was expected between blaGES-2 and blaGES-1/IBC amplification products. However, Tm analyses of blaGES-2 and blaGES-1 products obtained from control isolates demonstrated a difference of 7.8 to 9.84°C, whereas blaGES-2- and blaIBC-type products exhibited a temperature difference of 8.64 to 10.42°C (Table 4). Analyses of 83 blaGES-2 clinical isolates yielded a Tm of 55.63 ± 0.33°C, clearly distinguishing the 2-nt mismatch from blaGES-1-type amplification products (Fig. 2). Where there was an exact match between the sensor probe and the template sequence, Tm values of 64.07 ± 0.72°C (blaGES-1) and 64.78 ± 0.59°C (blaIBC) were found (Table 4), in comparison with 66°C reported previously (16). One clinical isolate with a Tm of 66.83°C yielded a blaGES-1 product on sequence analysis, making this the first report of β-lactamase GES-1 from a South African P. aeruginosa clinical isolate. Currently, molecular detection of ESBL-encoding genes from P. aeruginosa is the only reliable method available and, as such, the LightCycler has proved to be sensitive and highly specific in the rapid detection of ESBL genes of the GES/IBC family from P. aeruginosa.

TABLE 4.

Results obtained with nested PCR, real-time PCR, and DNA sequencing methods

Method Isolate type No. blaGES/IBC amplification positive No. blaGES/IBC amplification negative No. of amplicons analyzed Tm (°C) ± SD Sequencing result
Nested PCR Clinicala 88 12 87 blaGES-2
1 blaGES-1
Real-time PCR Clinicala 83 17
Melting curve analyses Clinical 82 55.63 ± 0.33 blaGES-2
Clinical 1 66.83 blaGES-1
GES-2 controlsb 55.25 ± 0.3
GES-1 controlb 64.07 ± 0.72
IBC controlsb 64.78 ± 0.59
a

All isolates tested were resistant to ceftazidime.

b

Control isolates were shown in Table 1.

FIG. 2.

FIG. 2.

Melting peaks of blaGES-1, blaGES-2, and E. coli ATCC 25922 (blaGES/IBC template-negative control). Amplification products are plotted as the negative derivative of fluorescence F2 [(−d(F2)/dT)] versus temperature. The Tm difference between an exact sensor probe match (GES-1) and a 2-nt mismatch (GES-2) is clearly visible. No melting peak was generated with the negative control isolate.

Acknowledgments

Funding was obtained from the Research Development Programme of the University of Pretoria.

I thank Patrice Nordmann, Eva Tselepi, and Leonidas Tsouvelekis for reference strains provided. Austen Cohen, Alexander Myburg, Oliver Preisig, Andrea Prinsloo, and Maureen B. Taylor are thanked for their contributions.

REFERENCES

  • 1.Arlet, G., G. Brami, D. Decre, A. Flippo, O. Gaillot, P. H. Lagrange, and A. Phillipon. 1995. Molecular characterization by PCR-restriction fragment length polymorphism of TEM β-lactamases. FEMS Microbiol. Lett. 134:203-208. [DOI] [PubMed] [Google Scholar]
  • 2.Bradford, P. A. 2001. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14:933-951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Castanheira, M., R. E. Mendes, T. R. Walsh, A. C. Gales, and R. N. Jones. 2004. Emergence of the extended-spectrum β-lactamase GES-1 in a Pseudomonas aeruginosa strain from Brazil: report from the SENTRY antimicrobial surveillance program. Antimicrob. Agents Chemother. 48:2344-2345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Giakkoupi, P., L. S. Tsouvelekis, A. Tsakris, V. Loukova, D. Sofianou, and E. Tzelepi. 2000. IBC-1, a novel integron-associated class A β-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain. Antimicrob. Agents Chemother. 44:2247-2253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Hauben, L., L. Vauterin, E. R. B. Moore, B. Hoste, and J. Swings. 1999. Genomic diversity of the genus Stenotrophomonas. Int. J. Syst. Bacteriol. 49:1749-1760. [DOI] [PubMed] [Google Scholar]
  • 6.Kim, J., and H. J. Lee. 2000. Rapid discriminatory detection of genes coding for SHV β-lactamases by ligase chain reaction. Antimicrob. Agents Chemother. 44:1860-1864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Lee, M.-K., L. E. Williams, D. W. Warnock, and B. A. Arthington-Skaggs. 2004. Drug resistance genes and trailing growth in Candida albicans isolates. J. Antimicrob. Chemother. 53:217-224. [DOI] [PubMed] [Google Scholar]
  • 8.Mabilat, C., and P. Courvalin. 1990. Development of “oligotyping” for characterization and molecular epidemiology of TEM β-lactamases in members of the family Enterobacteriaceae. Antimicrob. Agents Chemother. 34:2210-2216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Mavroidi, A., E. Tzelepi, A. Tsakris, et al. 2001. An integron-associated beta-lactamase (IBC-2) from Pseudomonas aeruginosa is a variant of the extended-spectrum beta-lactamase IBC-1. J. Antimicrob. Chemother. 48:627-630. [DOI] [PubMed] [Google Scholar]
  • 10.Mzali, F. H., J. Heritage, D. M. Gascoyne-Binzi, A. M. Snelling, and P. M. Hawkey. 1998. PCR single strand conformational polymorphism can be used to detect the gene encoding SHV-7 extended-spectrum β-lactamase and to identify different SHV genes within the same strain. J. Antimicrob. Chemother. 41:123-125. [DOI] [PubMed] [Google Scholar]
  • 11.National Committee for Clinical Laboratory Standards. 2003. Performance standards for antimicrobial disk susceptibility tests. 8th ed. Approved standard M2-A8. National Committee for Clinical Laboratory Standards, Wayne, Pa.
  • 12.Niederhauser, C., L. Kaempf, and I. Heinzer. 2000. Use of the ligase detection reaction-polymerase chain reaction to identify point mutations in extended-spectrum β-lactamases. Eur. J. Clin. Microbiol. Infect. Dis. 19:477-480. [DOI] [PubMed] [Google Scholar]
  • 13.Philippon, L. N., T. Naas, A.-T. Bouthors, V. Barakett, and P. Nordmann. 1997. OXA-18, a class D clavulanic acid-inhibited extended-spectrum β-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 41:2188-2195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Poirel, L., G. F. Weldhagen, T. Naas, C. de Champs, M. G. Dove, and P. Nordmann. 2001. GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob. Agents Chemother. 45:2598-2603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Poirel, L., I. Le Thomas, T. Naas, A. Karim, and P. Nordmann. 2000. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum β-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob. Agents Chemother. 44:622-632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Randegger, C. C., and H. Hächler. 2001. Real-time PCR and melting curve analysis for reliable and rapid detection of SHV extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 45:1730-1736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Wachino, J., Y. Doi, K. Yamane et al. 2004. Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class A β-lactamase, GES-3, in a neonatal intensive care unit in Japan. Antimicrob. Agents Chemother. 48:1960-1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Weldhagen, G. F. 2004. Integrons and β-lactamases—a novel perspective on resistance. Int. J. Antimicrob. Agents 23:556-562. [DOI] [PubMed] [Google Scholar]
  • 19.Weldhagen, G. F. 2004. Sequence-selective recognition of extended-spectrum β-lactamase GES-2 by a competitive, peptide nucleic acid-based multiplex PCR assay. Antimicrob. Agents Chemother. 48:3402-3406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Weldhagen, G. F., L. Poirel, and P. Nordmann. 2003. Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. Antimicrob. Agents Chemother. 47:2385-2392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Wolffs, P., H. Grage, O. Hagberg, and P. Rådström. 2004. Impact of DNA polymerases and their buffer systems on quantitative real-time PCR. J. Clin. Microbiol. 42:408-411. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES